The Effect of Impaired Hepatic Function on the Pharmacokinetics of LY2216684.

Trial Profile

The Effect of Impaired Hepatic Function on the Pharmacokinetics of LY2216684.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2013

At a glance

  • Drugs Edivoxetine (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 11 Mar 2011 Planned end date changed from 1 May 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.
    • 24 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top